S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains
about
S100A14 stimulates cell proliferation and induces cell apoptosis at different concentrations via receptor for advanced glycation end products (RAGE)Structural characterization of S100A15 reveals a novel zinc coordination site among S100 proteins and altered surface chemistry with functional implications for receptor bindingRole of S100 Proteins in Colorectal CarcinogenesisRAGE: a new frontier in chronic airways diseaseStructural Basis for Ligand Recognition and Activation of RAGEAdvanced Glycation End Product Recognition by the Receptor for AGEsStable RAGE-Heparan Sulfate Complexes Are Essential for Signal TransductionTIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand bindingEndothelin-Mediated Changes in Gene Expression in Isolated Purified Rat Retinal Ganglion CellsThe design and delivery of a thermally responsive peptide to inhibit S100B-mediated neurodegenerationTranilast Blocks the Interaction between the Protein S100A11 and Receptor for Advanced Glycation End Products (RAGE) V Domain and Inhibits Cell ProliferationRAGE signaling in inflammation and arterial aging.Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis.Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands.Expression of S100A6 in rat hippocampus after traumatic brain injury due to lateral head acceleration.Transcriptome-based analysis of kidney gene expression changes associated with diabetes in OVE26 mice, in the presence and absence of losartan treatmentAlteration of Aβ metabolism-related molecules in predementia induced by AlCl3 and D-galactoseDiscovery of circulating proteins associated to knee radiographic osteoarthritis.Characterization of αX I-Domain Binding to Receptors for Advanced Glycation End Products (RAGE)The danger signal S100B integrates pathogen- and danger-sensing pathways to restrain inflammationSweating the small stuff: microRNAs and genetic changes define pancreatic cancer.Carboxylated N-glycans on RAGE promote S100A12 binding and signaling.Adipocytes as an Important Source of Serum S100B and Possible Roles of This Protein in Adipose Tissue.S100A11, a dual growth regulator of epidermal keratinocytes.Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation.Cell migration is regulated by AGE-RAGE interaction in human oral cancer cells in vitro.Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis.Renal gene and protein expression signatures for prediction of kidney disease progressionS100A9 induced inflammatory responses are mediated by distinct damage associated molecular patterns (DAMP) receptors in vitro and in vivo.Adaptive evolution of the MHC class III-encoded receptor RAGE in primates and murine rodents.S100 proteins in cartilage: role in arthritis.Small Molecule Inhibition of Ligand-Stimulated RAGE-DIAPH1 Signal TransductionLysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling.CD166/ALCAM mediates proinflammatory effects of S100B in delayed type hypersensitivityHippocampal RAGE immunoreactivity in early and advanced Alzheimer's diseaseFunctions of S100 proteins.RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation.AKT pathway in neuroblastoma and its therapeutic implication.Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer.The N-glycoform of sRAGE is the key determinant for its therapeutic efficacy to attenuate injury-elicited arterial inflammation and neointimal growth.
P2860
Q21135467-BA4D9C79-4C40-496C-8606-282DAEEFBF41Q24607017-E455AA30-21BB-421F-8708-1A6E9721127EQ26765942-D6C38F50-242B-4987-96FA-5BBB30C12982Q27025295-44CA9ED7-C04A-4E0E-95D5-77BB7CE66A6BQ27665039-3FF4C639-015A-4866-9EA4-49583F06617AQ27667822-8676D9DC-0F90-44A3-B99D-02BCA900246BQ27678167-805E3589-7F74-4766-A622-775D328E0CD4Q28741936-179C29EB-CD4C-41FA-B1DD-F803740D1586Q30370132-CB2C7B83-5760-4CCD-B510-3FC4EC75EAD1Q30460371-FD33A163-785E-4F34-BA32-9A64F17A8F83Q31102154-A481C457-7C90-4D91-8BC1-F27B0F1C5C96Q33346824-69662F91-ECBD-4524-BEE8-29469CDC9781Q33367473-E8F93102-468E-4A92-B7A2-C9CC7254558EQ33389069-ADF04F6C-C48F-4352-B16C-06B3EAC98ECCQ33580678-822AB28D-DAB3-430C-951E-3DD3B49840D0Q33610151-6D55368E-48BC-405D-9ED1-BC1A83FFB4F7Q33617218-11A2E7F5-49EC-46CB-9E13-EDA2828A5072Q33669014-F99C4FDF-D098-4E6D-A82A-516F162CD901Q33775126-1830BAD0-B54B-40EB-A03A-BB9CE729B977Q33851482-55AA6745-F999-4459-B359-CC2F8133B5CFQ33862088-69F3F5E2-B38B-4739-9F45-E7D4C5CB1BECQ33890233-54C329B3-A767-4C79-9FF2-A6593820CA7EQ34002819-FE9BD066-944D-4570-9296-CB1F44815236Q34140211-9B5CB744-1A5C-4A44-959C-551AEBECE086Q34242174-808FCDE8-F46A-4AD4-BA91-DF8C9BA440FCQ34352301-981EB2B3-3CB0-4BAB-8BC4-86E65B4EF9DFQ34928842-6811E969-1C7B-4FC1-A8DF-E7B4C5DE4305Q34982782-C5FB9178-4CBB-4E4D-8E14-7D5304E24559Q35112587-633E1EB8-2C17-4B9C-B3B9-9779F9A24D63Q35780980-85A5805C-33E1-468B-9E89-BC7EFA6B755EQ35803078-05396B03-93DD-4CCB-B1D0-9C942A069EFDQ35943768-AD253983-85AC-437F-9BBD-1E35874F722FQ36478250-5B5AC7AC-2A23-4D35-88BA-EB2CE3A144B6Q36948770-6B60EC00-28C3-4ED8-BD31-E91952143E0CQ36977898-A111ADAD-D452-4311-8EAA-02D1AE3C5CB3Q37001259-92BA5531-531E-40B8-8ECC-1470DD970D07Q37152947-41A116AE-0746-4946-ACFA-89D634464104Q37159523-109DD193-4A15-410D-A48D-45F2B5F0D473Q37229916-2D935FBD-C473-4476-A2E0-7941C3FB8EAEQ37355646-6E96C435-DC3C-4532-AE75-5A155E610E23
P2860
S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
S100B and S100A6 differentiall ...... oducts) immunoglobulin domains
@ast
S100B and S100A6 differentiall ...... oducts) immunoglobulin domains
@en
S100B and S100A6 differentiall ...... oducts) immunoglobulin domains
@en-gb
S100B and S100A6 differentiall ...... oducts) immunoglobulin domains
@nl
type
label
S100B and S100A6 differentiall ...... oducts) immunoglobulin domains
@ast
S100B and S100A6 differentiall ...... oducts) immunoglobulin domains
@en
S100B and S100A6 differentiall ...... oducts) immunoglobulin domains
@en-gb
S100B and S100A6 differentiall ...... oducts) immunoglobulin domains
@nl
prefLabel
S100B and S100A6 differentiall ...... oducts) immunoglobulin domains
@ast
S100B and S100A6 differentiall ...... oducts) immunoglobulin domains
@en
S100B and S100A6 differentiall ...... oducts) immunoglobulin domains
@en-gb
S100B and S100A6 differentiall ...... oducts) immunoglobulin domains
@nl
P2093
P2860
P3181
P356
P1476
S100B and S100A6 differentiall ...... oducts) immunoglobulin domains
@en
P2093
Arnaud Galichet
Claus W Heizmann
Estelle Leclerc
Günter Fritz
Mirjam Weibel
P2860
P304
P3181
P356
10.1074/JBC.M703951200
P407
P577
2007-10-26T00:00:00Z